Drugs / bupropione
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02752542 | Oct 2016 → Jun 2026 overdue | dysthymic disorder, major depressive disorder | Nova Scotia Health Authority | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bupropione | “Augmentation (aripiprazole 2-10mg, bupropione 150-450mg) will be offered to participants with partial response.” NCT02752542 ↗ |